Hansen, Thomas Mejer https://orcid.org/0000-0003-4529-0112
Christensen, Nana Louise https://orcid.org/0000-0002-9936-1636
Vendelbo, Mikkel Holm https://orcid.org/0000-0003-0431-2522
Funding for this research was provided by:
Beta.Health Denmark (2024-1792)
Article History
Received: 23 December 2025
Accepted: 1 July 2026
First Online: 15 July 2026
Declarations
Ethics approval and consent to participate: The study was approved by the Danish National Committee on Health Research Ethics (Case no. 2313915).
Competing interests: Thomas Mejer Hansen is the CEO of NoloSight ApS, a company developing AI-based solutions for medical imaging. The other authors declare that they have no conflict of interest.